Eye Health News and Research

Latest Eye Health News and Research

MUHC's Henry C. Witelson Ocular Pathology Laboratory celebrates tenth anniversary

The Burnier International Ocular Pathology Society is holding a Scientific Colloquium in Montreal today to mark the tenth anniversary of the McGill University Health Centre's Henry C. Witelson Ocular Pathology Laboratory. The lab is an internationally reputed centre for the study and treatment of eye diseases and is leading a global network for the sharing of healthcare knowledge and expertise.

7 May 2010

First clinical trial results of camera chip implanted under retina presented at 2010 ARVO meeting

Retina Implant, AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of findings from their first clinical trial in which blind patients were able to view and focus on objects as their eye and head naturally moved as opposed to needing to constantly move their head to scan a scene, which is the case for other implants in which a camera is mounted to the patient's head.

7 May 2010

Resolvyx presents new data on RX-10001 for corneal herpes simplex virus infection at ARVO 2010

Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced the presentation of data on its novel resolvins for the treatment of both ocular surface diseases and retinal diseases at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale, Florida, being held May 2-6, 2010.

7 May 2010

Neuroscientists show how individual neurons carry significant aspects of sensory processing

Pioneering a novel microscopy method, neuroscientist Arthur Konnerth and colleagues from the Technische Universitaet Muenchen (TUM) have shown that individual neurons carry out significant aspects of sensory processing: specifically, in this case, determining which direction an object in the field of view is moving.

7 May 2010

Pfizer presents data on in vivo activity of PF-04523655 siRNA drug candidate at ARVO annual meeting

Quark Pharmaceuticals, Inc., the world leader in clinical development of RNAi-based therapeutics, announced today that researchers from Pfizer, Inc. presented data on in vivo activity of PF-04523655 at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, being held May 2-6, 2010 in Fort Lauderdale.

7 May 2010

Researchers use new tools to study how brain responds when injury occurs

Researchers at four institutions, led by Stanford University and Brown University, have begun an effort with more than $14 million of federal funding to learn both how the brain and its microcircuitry react to sudden physiological changes and what can be done to encourage recovery from injury.

6 May 2010

Promising new generation of contact lenses for myopia control

An international team of researchers tested a contact lens that may reduce the progress of nearsightedness, or myopia, by fully correcting the central vision but reducing the relative peripheral farsightedness, or hyperopia.

6 May 2010

Lack of physical activity and greater TV viewing time associated with wider retinal venules

It is well known that the lack of physical activity is a risk factor for cardiovascular diseases, but what part does it play in retinal vascular caliber? A team of researchers examined the association of physical activity and television viewing time with retinal vascular caliber and explored the differences in white, black, Hispanic and Chinese racial/ethnic groups.

6 May 2010

Round-up: Minnesota budget news; Coverage expansions in S.D. and Oregon; and states' opposition to federal health reform

The Minnesota House passed a bill on health care Tuesday that readies the state for implementing the federal health care overhaul and makes $170 million in cuts to mental health and other social programs, The (St. Paul, Minn.) Pioneer Press reports. Gov. Tim Pawlenty has promised to veto the bill over what he sees as a tax increase.

6 May 2010

Patients Medical provides patients with valuable tips to prevent Lyme disease

Patients Medical, a leading integrative and holistic medical center in New York City, is supporting National Lyme Disease Awareness month by providing patients with valuable tips to prevent the disease, as well as education on the best treatment options available.

6 May 2010

Research may promote better diagnosis and treatment for glaucoma

Glaucoma, the second leading cause of blindness worldwide, tends to progress silently until decreased vision indicates trouble, said Dr. Kathryn Bollinger, Medical College of Georgia clinician-scientist specializing in glaucoma.

6 May 2010

New combination eye drops effective in treating bacterial keratitis

Scientists are reporting development of a potential new way of enabling patients with bacterial keratitis to stick with the extraordinarily intensive treatment needed for this potentially blinding eye infection.

6 May 2010

Caffeine is effective in preventing cataract formation, says study

Caffeine may be effective in protecting the lens against damage that could lead to the formation of cataracts, according to a study presented on May 4 at the 2010 Annual Meeting of the Association for Research in Vision and Ophthalmology.

6 May 2010

Scientists use specialized fluorescent protein to study nerve cell activity

Electrical currents are invisible to the naked eye - at least they are when they flow through metal cables. In nerve cells, however, scientists are able to make electrical signals visible. Working with fellow experts from Switzerland and Japan, scientists from the Max Planck Institute for Medical Research in Heidelberg successfully used a specialized fluorescent protein to visualize electrical activity in neurons of living mice.

6 May 2010

TearScience completes $44.5 million Series C funding

TearScience, a privately-held medical device company, today announced the completion of $44.5 million of Series C funding from new investors Essex Woodlands Health Ventures, Investor Growth Capital and General Catalyst. The company's existing investors, De Novo Ventures, Spray Ventures and Quaker Bio Ventures completed the round. The funding will allow TearScience to commercialize its devices designed for use by eye care professionals to diagnose and treat the most common form of chronic dry eye disease.

5 May 2010

StemCells first-quarter total revenue up 307%

StemCells, Inc., a leading stem cell technology company with the dual focus of novel therapeutics and innovative research products, today reported financial results for the first quarter ended March 31, 2010 and recent business highlights.

5 May 2010

IBI to present data on Verisome Liquid Drug Delivery System for cystoid macular edema at ARVO 2010

Icon Bioscience, Inc., (IBI), a privately held biopharmaceutical company that specializes in the development and commercialization of novel ophthalmic pharmaceuticals announced today that it will present an abstract demonstrating the utility of its Verisome™ Liquid Drug Delivery System in cystoid macular edema, at the Association for Research in Vision and Ophthalmology (ARVO) 2010 annual meeting, taking place May 2-6, 2010, in Fort Lauderdale, Florida.

5 May 2010

Australia to introduce plain cigarette packaging

Cigarettes in Australia will soon have to be sold in plain packaging to prevent consumers - and particularly children - from being influenced by tobacco advertising.

4 May 2010

Early treatment of ROP for high-risk premature babies can improve vision: ETROP study

Scientists have shown that through eye examinations, doctors can identify infants who are most likely to benefit from early treatment for a potentially blinding eye condition called retinopathy of prematurity, resulting in better vision for many children.

4 May 2010

Merck reports non-GAAP EPS of $0.83 for first-quarter 2010

Merck & Co., Inc. today announced financial results for the first quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the first quarter of $0.83, which excludes purchase accounting adjustments, merger-related expenses and restructuring costs, as well as a tax charge related to the recently enacted health care reform legislation. First-quarter GAAP EPS was $0.09.

4 May 2010

Eye Health News and Research

Latest Eye Health News and Research

MUHC's Henry C. Witelson Ocular Pathology Laboratory celebrates tenth anniversary

First clinical trial results of camera chip implanted under retina presented at 2010 ARVO meeting

Resolvyx presents new data on RX-10001 for corneal herpes simplex virus infection at ARVO 2010

Neuroscientists show how individual neurons carry significant aspects of sensory processing

Pfizer presents data on in vivo activity of PF-04523655 siRNA drug candidate at ARVO annual meeting

Researchers use new tools to study how brain responds when injury occurs

Promising new generation of contact lenses for myopia control

Lack of physical activity and greater TV viewing time associated with wider retinal venules

Round-up: Minnesota budget news; Coverage expansions in S.D. and Oregon; and states' opposition to federal health reform

Patients Medical provides patients with valuable tips to prevent Lyme disease

Research may promote better diagnosis and treatment for glaucoma

New combination eye drops effective in treating bacterial keratitis

Caffeine is effective in preventing cataract formation, says study

Scientists use specialized fluorescent protein to study nerve cell activity

TearScience completes $44.5 million Series C funding

StemCells first-quarter total revenue up 307%

IBI to present data on Verisome Liquid Drug Delivery System for cystoid macular edema at ARVO 2010

Australia to introduce plain cigarette packaging

Early treatment of ROP for high-risk premature babies can improve vision: ETROP study

Merck reports non-GAAP EPS of $0.83 for first-quarter 2010

Genetics & Genomics - Second Edition eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in